Arcutis Officer Files Intent to Sell $178K in Stock (ARQT)
Arcutis Biotherapeutics, Inc.
Subscribe to track ARQT
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Arcutis Officer Files Intent to Sell $178K in Stock (ARQT)
Company: Arcutis Biotherapeutics, Inc. (ARQT) Form: 144 | Filed: 2025-11-03 Significance: Low
Insider: Masaru Matsuda Title: Officer | Relationship: Officer
Transaction: • Type: Proposed Sale • Shares: 7,208 • Price: ~$24.72 • Value: $178,155 • Owned After: Not Disclosed
Key Insight: An officer has filed a notice of a proposed sale of shares valued at $178k. The transaction size is negligible compared to the company's $3.05B market cap, representing less than 0.01% of market value and shares outstanding.
Market Context: The shares were acquired via restricted stock vesting just prior to this notice. The insider has also sold shares in the preceding months, suggesting a pattern of periodic selling.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: Arcutis Biotherapeutics, Inc. (ARQT)
Executive Summary
- Trading Significance: Low
- Key Takeaway: An officer of Arcutis Biotherapeutics filed a Form 144, signaling intent to sell 7,208 shares valued at approximately $178,155.
- Market Impact: The transaction is of low significance and is unlikely to have a material impact on the stock price due to its small size relative to the company's market capitalization.
Company Information
| Field | Value |
|---|---|
| Company | Arcutis Biotherapeutics, Inc. |
| Ticker Symbol | ARQT |
| CIK | 0001787306 |
| Industry | PHARMACEUTICAL PREPARATIONS |
Insider Information
| Field | Value |
|---|---|
| Name | Masaru Matsuda |
| CIK | 0001798679 |
| Title/Position | Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 144 |
| Transaction Date | 2025-11-03 (Approximate Sale Date) |
| Transaction Code | Not Applicable (Form 144) |
| Security Type | Common Stock |
| Shares Involved | 7,208 |
| Price Per Share | ~$24.72 |
| Total Value | $178,155 |
| Shares Owned After | Not Disclosed |
| Ownership Type | Not Disclosed |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $178,155 |
| % of Market Cap | 0.006% |
| Shares Transacted | 7,208 |
| % of Shares Outstanding | 0.006% |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a company with a market capitalization of $3.05 billion, this $178k transaction is financially immaterial.
- Transaction Significance: The sale represents a negligible fraction of both the market capitalization (0.006%) and the total shares outstanding (0.006%), falling well below any threshold for significance. Such sales are common for executives managing personal finances or covering taxes on vested equity.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The proposed sale is too small to influence market sentiment or trading activity. It is a routine filing that does not signal a change in the insider's outlook on the company.
Volume & Sentiment
- Expected Volume Impact: Negligible. The number of shares is a tiny fraction of typical daily trading volume.
- Sentiment Indicator: Neutral. The market is unlikely to react to this filing.
Additional Context
Transaction Notes
- The filing is a Form 144, which is a notice of proposed sale, not a confirmation of a completed trade.
- The shares were acquired through the vesting of restricted stock on November 1, 2025. It is common for insiders to sell a portion of vested shares.
- The same insider also sold shares in August and September 2025, indicating a potential pattern of regular, planned selling.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.